The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...
Vous n'êtes pas connecté
The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...
The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...
INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...
INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...
TUESDAY, Sept. 30, 2025 -- The U.S. Food and Drug Administration has approved Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the...
TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...
TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...
TUESDAY, Sept. 30, 2025 (HealthDay News) --...
TUESDAY, Sept. 30, 2025 (HealthDay News) --...
TUESDAY, Sept. 30, 2025 (HealthDay News) --...
"FDA approved INLURIYO (imlunestrant) by Eli Lilly, on September 25, 2025" The pharmaceutical landscape for metastatic breast cancer treatment has...